Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Arca Biopharma (ABIO)
NASDAQ:ABIO
Arca Biopharma (ABIO) Stock Price & Analysis
422 Followers
ABIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.76 - $2.70
Previous Close$2.07
Volume20.51K
Average Volume (3M)34.08K
Market Cap
$29.82M
Enterprise Value-$12.35M
Total Cash (Recent Filing)$42.45M
Total Debt (Recent Filing)$280.00K
Price to Earnings (P/E)-3.0
Beta0.33
Next Earnings
May 09, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding14,410,143
10 Day Avg. Volume36,467
30 Day Avg. Volume34,078
Standard Deviation0.36
R-Squared0.05
Alpha-0.00634
Financial Highlights & Ratios
Price to Book (P/B)0.72
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda1.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Arca Biopharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ABIO FAQ
What was Arca Biopharma’s price range in the past 12 months?
Arca Biopharma lowest stock price was $1.76 and its highest was $2.70 in the past 12 months.
What is Arca Biopharma’s market cap?
Currently, no data Available
When is Arca Biopharma’s upcoming earnings report date?
Arca Biopharma’s upcoming earnings report date is May 09, 2023 which is in 41 days.
How were Arca Biopharma’s earnings last quarter?
Arca Biopharma released its earnings results on Feb 24, 2023. The company reported -$0.082 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.082.
Is Arca Biopharma overvalued?
According to Wall Street analysts Arca Biopharma’s price is currently Overvalued.
Does Arca Biopharma pay dividends?
Arca Biopharma does not currently pay dividends.
What is Arca Biopharma’s EPS estimate?
Arca Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Arca Biopharma have?
Arca Biopharma has 14,410,143 shares outstanding.
What happened to Arca Biopharma’s price movement after its last earnings report?
Arca Biopharma reported an EPS of -$0.082 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.828%.
Which hedge fund is a major shareholder of Arca Biopharma?
Currently, no hedge funds are holding shares in ABIO
---
Arca Biopharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.87%
12-Months-Change
Fundamentals
Return on Equity
-21.41%
Trailing 12-Months
Asset Growth
-21.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Arca Biopharma
ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.
---
Top 5 ETFs holding ABIO
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold ABIO. The ETFs are listed according to market value of ABIO within the ETF
---
BioCardia
―
Monopar Therapeutics Inc
―
Diamedica Therapeutics
―
NightHawk Biosciences
―
Vicapsys Life Sciences
―
---